시장보고서
상품코드
1762255

마이크로바이옴 시퀀싱 서비스 시장 규모, 점유율, 동향, 산업 분석 보고서 : 기술, 용도, 최종 용도, 지역별 - 시장 예측(2025-2034년)

Microbiome Sequencing Services Market Size, Share, Trends, Industry Analysis Report: By Technology, Application, End Use, and Region - Market Forecast, 2025-2034

발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 120 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 마이크로바이옴 시퀀싱 서비스 세계 시장 규모는 2034년까지 46억 5,410만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

마이크로바이옴 시퀀싱 서비스는 16S rRNA 유전자 시퀀싱, 샷건 메타유전체, 메타트랜스criptomics 등 첨단 시퀀싱 기술을 통한 미생물 군집 분석을 포함합니다. 이러한 서비스는 인간의 장, 피부, 토양, 물 등 다양한 환경에서 미생물의 동정 및 특성 분석에 널리 활용되고 있습니다. 미생물의 다양성과 기능적 역할에 대한 인사이트를 제공함으로써 마이크로바이옴 시퀀싱은 질병 연구, 맞춤 의료, 의약품 개발, 농업, 환경 연구에 중요한 역할을 하고 있습니다.

마이크로바이옴 시퀀싱 서비스 시장의 성장은 인간의 건강과 질병에서 마이크로바이옴의 역할에 대한 연구가 증가함에 따라 이루어지고 있습니다. 주요 촉진요인으로는 차세대 염기서열 분석(NGS) 기술의 발전, 정부 기관 및 민간 단체의 투자 증가, 질병 진단 및 치료에 대한 적용 확대 등을 들 수 있습니다. 또한, 맞춤형 의료, 프로바이오틱스, 마이크로바이옴 기반 의약품 개발에 대한 수요 증가는 AI를 활용한 바이오인포매틱스, 전략적 제휴, 개발도상국 서비스 확대 등 마이크로바이옴 시퀀싱 서비스의 새로운 시장 기회를 창출하고 있습니다. 신흥국 시장 동향은 시장 확대를 더욱 촉진하고 있습니다. 마이크로바이옴 연구가 헬스케어, 농업, 환경과학 분야에서 지속적으로 중요성이 증가함에 따라 시퀀싱 서비스에 대한 수요는 예측 기간 동안 확대될 것으로 예상됩니다.

마이크로바이옴 시퀀싱 서비스 시장 보고서 하이라이트

기술별로 보면 합성 시퀀싱 부문은 높은 정확도, 비용 효율성, 차세대 염기서열 분석(NGS) 플랫폼의 광범위한 채택으로 인해 마이크로바이옴 시퀀싱 서비스 시장 수익에서 가장 큰 비중을 차지하고 있습니다.

용도별로는 소화기 질환 분야가 2024년 가장 큰 시장 점유율을 차지했습니다. 이러한 우위는 소화기 건강 유지에 있어 장내 미생물의 중요한 역할과 다양한 소화기 질환과의 연관성에 기인합니다.

지역별로는 북미가 세계 마이크로바이옴 시퀀싱 서비스 시장에서 가장 큰 점유율을 차지하고 있는데, 이는 주로 헬스케어 인프라가 잘 구축되어 있고, 유전체학 및 미생물학 연구개발 활동이 활발하기 때문입니다.

유럽의 마이크로바이옴 시퀀싱 서비스 시장은 유전성 질환의 유병률 증가와 셀프 메디케이션에 대한 선호도가 높아지면서 큰 폭의 성장세를 보이고 있습니다.

이 시장에는 성장과 혁신에 기여하는 여러 주요 기업들이 활발하게 활동하고 있습니다. 주목할 만한 기업으로는 Baseclear B.V., Clinical Microbiomics A/S., Merieux NutriSciences Corporation, Metabiomics Corp. Microbiome Therapeutics, LLC, Molzym GmbH & Co.KG, MR DNA, Resphera Biosciences, LLC, Zymo Research Corporation 등이 있습니다.

목차

제1장 소개

제2장 주요 요약

제3장 조사 방법

제4장 세계의 마이크로바이옴 시퀀싱 서비스 시장 인사이트

  • 시장 현황
  • 마이크로바이옴 시퀀싱 서비스 시장 역학
    • 성장 촉진요인과 기회
      • 시퀀싱 기술의 진보
      • 정부 이니셔티브와 자금
    • 성장 억제요인과 과제
      • 시퀀싱과 데이터 분석의 고비용
  • PESTEL 분석
  • 마이크로바이옴 시퀀싱 서비스 시장 애플리케이션 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 마이크로바이옴 시퀀싱 서비스 시장 : 기술별

  • 주요 조사 결과
  • 소개
  • 합성에 의한 배열 결정
  • 결찰에 의한 배열 결정
  • 생어 시퀀싱
  • 기타

제6장 세계의 마이크로바이옴 시퀀싱 서비스 시장 : 용도별

  • 주요 조사 결과
  • 소개
  • 자가면역질환
  • 위장장애
  • 기타

제7장 세계의 마이크로바이옴 시퀀싱 서비스 시장 : 최종 용도별

  • 주요 조사 결과
  • 소개
  • 제약·바이오테크놀러지 기업
  • 학술연구기관
  • 기타

제8장 세계의 마이크로바이옴 시퀀싱 서비스 시장 : 지역별

  • 주요 조사 결과
  • 소개
    • 마이크로바이옴 시퀀싱 서비스 시장 분석 : 지역별, 2020-2034년
  • 북미
    • 북미 : 기술별, 2020-2034년
    • 북미 : 용도별, 2020-2034년
    • 북미 : 최종 용도별, 2020-2034년
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 기술별, 2020-2034년
    • 유럽 : 용도별, 2020-2034년
    • 유럽 : 최종 용도별, 2020-2034년
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 기술별, 2020-2034년
    • 아시아태평양 : 용도별, 2020-2034년
    • 아시아태평양 : 최종 용도별, 2020-2034년
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 기술별, 2020-2034년
    • 중동 및 아프리카 : 용도별, 2020-2034년
    • 중동 및 아프리카 : 최종 용도별, 2020-2034년
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 남아프리카공화국
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 기술별, 2020-2034년
    • 라틴아메리카 : 용도별, 2020-2034년
    • 라틴아메리카 : 용도별, 2020-2034년
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제9장 경쟁 구도

  • 확대와 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제10장 기업 개요

  • Baseclear B.V.
  • BioSpherex LLC
  • Clinical Microbiomics A/S
  • Merieux NutriSciences Corporation
  • Metabiomics Corp.
  • Microbiome Insights Inc.
  • Microbiome Therapeutics, LLC.
  • Molzym GmbH & Co. KG
  • MR DNA
  • Phase Genomics
ksm 25.07.09

The global microbiome sequencing services market size is expected to reach USD 4,654.10 million by 2034, according to a new study by Polaris Market Research. The report "Microbiome Sequencing Services Market Size, Share, Trends, Industry Analysis Report: By Technology (Sequencing by Synthesis, Sequencing by Ligation, Sanger Sequencing, and Others), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Microbiome sequencing services involve the analysis of microbial communities through advanced sequencing technologies, including 16S rRNA gene sequencing, shotgun metagenomics, and metatranscriptomics. These services are widely used to identify and characterize microorganisms in various environments, such as the human gut, skin, soil, and water. By providing insights into microbial diversity and functional roles, microbiome sequencing plays a crucial role in disease research, personalized medicine, drug development, agriculture, and environmental studies.

The microbiome sequencing services market growth is attributed to increasing research on the role of microbiomes in human health and disease. Key drivers include advancements in next-generation sequencing (NGS) technologies, rising investments from government and private organizations, and growing applications in disease diagnostics and therapeutics. Additionally, the increasing demand for personalized medicine, probiotics, and microbiome-based drug development presents new market opportunities. Emerging microbiome sequencing services market trends such as AI-driven bioinformatics, strategic collaborations, and service expansion in developing regions are further supporting market expansion. As microbiome research continues to gain importance in healthcare, agriculture, and environmental sciences, the demand for sequencing services is expected to grow during the forecast period.

Microbiome Sequencing Services Market Report Highlights

By technology, the sequencing by synthesis segment holds the largest share of the microbiome sequencing services market revenue due to its high accuracy, cost efficiency, and widespread adoption in next-generation sequencing (NGS) platforms.

By application, the gastrointestinal disorders segment holds the largest market share in 2024. This prominence is attributed to the critical role of the gut microbiome in maintaining digestive health and its association with various gastrointestinal diseases.

By region, North America holds the largest share of the global microbiome sequencing services market, primarily due to its well-established healthcare infrastructure and significant research and development activities in genomics and microbiology.

The Europe microbiome sequencing services market is experiencing significant growth, driven by the increasing prevalence of genetic disorders and a rising preference for self-medication.

The market features several active key players contributing to its growth and innovation. Notable companies include Baseclear B.V.; Clinical Microbiomics A/S; Merieux NutriSciences Corporation; Metabiomics Corp.; Microbiome Insights Inc.; Microbiome Therapeutics, LLC; Molzym GmbH & Co. KG; MR DNA; Resphera Biosciences, LLC; Zymo Research Corporation; and others.

Polaris Market Research has segmented the microbiome sequencing services market report on the basis of technology, application, end use, and region:

By Technology Outlook (Revenue - USD Million, 2020-2034)

Sequencing by Synthesis

Sequencing by Ligation

Sanger Sequencing

Others

By Application Outlook (Revenue - USD Million, 2020-2034)

Autoimmune Disorder

Cancer

Gastrointestinal Disorders

Others

By End Use Outlook (Revenue - USD Million, 2020-2034)

Pharmaceutical & Biotechnology Companies

Academic Research Institutes

Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Microbiome Sequencing Services Market Insights

  • 4.1. Microbiome Sequencing Services Market - Market Snapshot
  • 4.2. Microbiome Sequencing Services Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in sequencing technologies
      • 4.2.1.2. Government initiatives and funding
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Sequencing and Data Analysis
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Microbiome Sequencing Services Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Microbiome Sequencing Services Market, by Technology

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
  • 5.3. Sequencing by synthesis
    • 5.3.1. Global Microbiome Sequencing Services Market, by Sequencing by synthesis, by Region, 2020-2034 (USD Million)
  • 5.4. Sequencing by ligation
    • 5.4.1. Global Microbiome Sequencing Services Market, by Sequencing by ligation, by Region, 2020-2034 (USD Million)
  • 5.5. Sanger sequencing
    • 5.5.1. Global Microbiome Sequencing Services Market, by Sanger sequencing, by Region, 2020-2034 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Microbiome Sequencing Services Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Microbiome Sequencing Services Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
  • 6.3. Autoimmune Disorder
    • 6.3.1. Global Microbiome Sequencing Services Market, by Autoimmune Disorder, by Region, 2020-2034 (USD Million)
  • 6.4. Cancer
    • 6.4.1. Global Microbiome Sequencing Services Market, by Cancer, by Region, 2020-2034 (USD Million)
  • 6.5. Gastrointestinal Disorders
    • 6.5.1. Global Microbiome Sequencing Services Market, by Gastrointestinal Disorders, by Region, 2020-2034 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Microbiome Sequencing Services Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Microbiome Sequencing Services Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
  • 7.3. Pharmaceutical & biotechnology companies
    • 7.3.1. Global Microbiome Sequencing Services Market, by Pharmaceutical & biotechnology companies, by Region, 2020-2034 (USD Million)
  • 7.4. Academic research institutes
    • 7.4.1. Global Microbiome Sequencing Services Market, by Academic research institutes, by Region, 2020-2034 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Microbiome Sequencing Services Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Microbiome Sequencing Services Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Microbiome Sequencing Services Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Microbiome Sequencing Services Market - North America
    • 8.3.1. North America: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
    • 8.3.2. North America: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.3.3. North America: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.3.4. Microbiome Sequencing Services Market - U.S.
      • 8.3.4.1. U.S.: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.3.4.2. U.S.: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.3.4.3. U.S.: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.3.5. Microbiome Sequencing Services Market - Canada
      • 8.3.5.1. Canada: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
  • 8.4. Microbiome Sequencing Services Market - Europe
    • 8.4.1. Europe: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
    • 8.4.2. Europe: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.3. Europe: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.4. Microbiome Sequencing Services Market - UK
      • 8.4.4.1. UK: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.5. Microbiome Sequencing Services Market - France
      • 8.4.5.1. France: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.4.5.2. France: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.4.5.3. France: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.6. Microbiome Sequencing Services Market - Germany
      • 8.4.6.1. Germany: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.7. Microbiome Sequencing Services Market - Italy
      • 8.4.7.1. Italy: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.8. Microbiome Sequencing Services Market - Spain
      • 8.4.8.1. Spain: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.9. Microbiome Sequencing Services Market - Netherlands
      • 8.4.9.1. Netherlands: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.10. Microbiome Sequencing Services Market - Russia
      • 8.4.10.1. Russia: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.11. Microbiome Sequencing Services Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
  • 8.5. Microbiome Sequencing Services Market - Asia Pacific
    • 8.5.1. Asia Pacific: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.4. Microbiome Sequencing Services Market - China
      • 8.5.4.1. China: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.5.4.2. China: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.5.4.3. China: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.5. Microbiome Sequencing Services Market - India
      • 8.5.5.1. India: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.5.5.2. India: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.5.5.3. India: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.6. Microbiome Sequencing Services Market - Malaysia
      • 8.5.6.1. Malaysia: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.7. Microbiome Sequencing Services Market - Japan
      • 8.5.7.1. Japan: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.8. Microbiome Sequencing Services Market - Indonesia
      • 8.5.8.1. Indonesia: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.9. Microbiome Sequencing Services Market - South Korea
      • 8.5.9.1. South Korea: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.10. Microbiome Sequencing Services Market - Australia
      • 8.5.10.1. Australia: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.11. Microbiome Sequencing Services Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
  • 8.6. Microbiome Sequencing Services Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.6.4. Microbiome Sequencing Services Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.6.5. Microbiome Sequencing Services Market - UAE
      • 8.6.5.1. UAE: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.6.6. Microbiome Sequencing Services Market - Israel
      • 8.6.6.1. Israel: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.6.7. Microbiome Sequencing Services Market - South Africa
      • 8.6.7.1. South Africa: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.6.8. Microbiome Sequencing Services Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
  • 8.7. Microbiome Sequencing Services Market - Latin America
    • 8.7.1. Latin America: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.7.4. Microbiome Sequencing Services Market - Mexico
      • 8.7.4.1. Mexico: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.7.5. Microbiome Sequencing Services Market - Brazil
      • 8.7.5.1. Brazil: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.7.6. Microbiome Sequencing Services Market - Argentina
      • 8.7.6.1. Argentina: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.7.7. Microbiome Sequencing Services Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Baseclear B.V.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. BioSpherex LLC
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Clinical Microbiomics A/S
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Merieux NutriSciences Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Metabiomics Corp.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Microbiome Insights Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Microbiome Therapeutics, LLC.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Molzym GmbH & Co. KG
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. MR DNA
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Phase Genomics
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제